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Background: Studies of protein association with DNA on a genome wide scale are possible through methods like
ChIP-Chip or ChIP-Seq. Massive problems with false positive signals in our own experiments motivated us to revise
the standard ChIP-Chip protocol. Analysis of chromosome wide binding of the alternative sigma factor σ32 in
Escherichia coli with this new protocol resulted in detection of only a subset of binding sites found in a previous
study by Wade and colleagues. We suggested that the remainder of binding sites detected in the previous study
are likely to be false positives. In a recent article the Wade group claimed that our conclusion is wrong and that the
disputed sites are genuine σ32 binding sites. They further claimed that the non-detection of these sites in our study
was due to low data quality.
Results/discussion: We respond to the criticism of Wade and colleagues and discuss some general questions of
ChIP-based studies. We outline why the quality of our data is sufficient to derive meaningful results. Specific points
are: (i) the modifications we introduced into the standard ChIP-Chip protocol do not necessarily result in a low
dynamic range, (ii) correlation between ChIP-Chip replicates should not be calculated based on the whole data set
as done in transcript analysis, (iii) control experiments are essential for identifying false positives. Suggestions are
made how ChIP-based methods could be further optimized and which alternative approaches can be used to
strengthen conclusions.
Conclusion: We appreciate the ongoing discussion about the ChIP-Chip method and hope that it helps other
scientist to analyze and interpret their results. The modifications we introduced into the ChIP-Chip protocol are a
first step towards reducing false positive signals but there is certainly potential for further optimization. The
discussion about the σ32 binding sites in question highlights the need for alternative approaches and further
investigation of appropriate methods for verification.
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In a recent article in this journal we described o.ur ex-
perience with application of the ChIP-Chip method [1].
Our focus was on the replication protein SeqA which
had been shown to be specific for hemi-methylated
GATC-sequences [2]. To gain a deeper understanding of
the DNA-binding of SeqA we applied a widely used
standard ChIP-Chip protocol [3]. As a proof that the
method works well in our hands we performed ChIP-
Chip experiments with RNA-polymerase antibody as
published previously [4]. To our great surprise the bind-
ing sites we detected for SeqA and RNAP were highly* Correspondence: Torsten.Waldminghaus@synmikro.uni-marburg.de
LOEWE-Center for Synthetic Microbiology (SYNMIKRO), Philipps-Universität
Marburg, Hans-Meerwein-Str. 6, D-35043, Marburg, Germany
© 2013 Schindler and Waldminghaus; licensee
of the Creative Commons Attribution License
distribution, and reproduction in any mediumsimilar. This was absolutely unexpected because many
SeqA-bound DNA-regions detected in this experiment
did not contain many of the established GATC binding
sequences. One possibility is that these non-canonical
protein-DNA interactions could be genuine binding sites
and therefore an indication that our understanding of
DNA-binding proteins is incomplete. We considered the
alternative possibility that our surprising results might
be artifacts. The key experiment to distinguish between
these explanations was a ChIP-Chip using a ΔseqA
strain with a SeqA antibody. Also in this experiment we
detected binding signals which unambiguously demon-
strated unspecifically enriched chromosomal regions via
the used standard method. The unspecific signals could
be caused by binding of non-target proteins by theBioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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critical for the quality of ChIP based methods [5,6].
However, the antibody turned out not to be the problem
in this case. Evaluation of the ChIP-Chip method led to
the identification of four causes for these false signals:
i) non-unique sequences, ii) incomplete reversion of
crosslinks, iii) inappropriate retention of protein in spin-
columns and iv) insufficient RNase treatment [1]. We
established a modified ChIP-Chip protocol to minimize
the effects of these sources of false positive ChIP peaks
and applied it using the SeqA antibody. The SeqA bind-
ing pattern detected with this new protocol was radically
different from the standard protocol with almost no
overlap. This means that specific details of a protocol
changed the chromosomal binding pattern completely.
The SeqA binding sites we detected with our modified
method were exclusively canonical binding sites with
binding signals being proportional to the number of
GATC sites in the respective regions. Thus, in the case
of SeqA the non-canonical protein-DNA interactions
identified with the standard ChIP-Chip method are
artifacts.
In 2006, Wade and colleagues published a ChIP-Chip
study on the alternative sigma factor σ32 [7]. In addition
to 38 known binding sites they surprisingly found 49
new non-canonical binding sites. These non-canonical
sites could be either genuine binding sites or artifacts.
Wade et al. concluded that these sites are genuine σ32
binging sites. Based on our experience with SeqA de-
scribed above we considered the possibility that these
non-canonical sites might instead be false positives. This
idea was supported by the lack of a control ChIP-Chip
experiment in the Wade et al. study and the fact that
they refer to the same protocol that gave the enormous
false positive rate in our first SeqA attempt [1]. In our
study, the ΔseqA control strain was crucial for identify-
ing false positives. We applied our modified ChIP-Chip
protocol to analyze σ32 binding on the E. coli chromo-
some. We detected almost all of the canonical σ32 bind-
ing sites but only very few of the non-canonical sites.
Taken together these findings led to the conclusion that
the majority of non-canonical σ32 sites described by
Wade et al. are probably not genuine binding sites but
instead false positives [1]. In a recent article in this jour-
nal Wade and colleagues published a new study claiming
that our conclusion was wrong and that the non-
canonical σ32 sites are in fact genuine binding sites [8].
They base their view on ChIP coupled with qPCR ana-
lyses of 4 out of the 49 “Disputed σ32 sites” (DSTs) and
the claim that the quality of our ChIP-Chip data is low
compared to their study. In addition they find that
the specific ChIP enrichment is reduced because of
the increased stringency changes we introduced into the
protocol. Here, we respond to the new study of theWade group and use this to discuss some critical ques-
tions surrounding ChIP-Chip analysis.
What is good data quality in ChIP-Chip studies?
As with most methods the quality of ChIP-Chip derived
data varies. This might be due to the details of the meth-
odology, the type and quality of the antibody, the
biological samples, as well as the performance and ex-
perience of the experimenter. Wade and colleagues
reanalyzed their own and our data regarding dynamic
range and reproducibility and concluded that both as-
pects were better in their study. We appreciate if other
scientists re-analyze our data to come to their own con-
clusion. This is why we routinely store our ChIP-Chip
data in public databases such as the Gene Expression
Omnibus (GEO) which is publically accessible. The re-
quired detailed description of experimental procedures
and data processing together with storage of raw as well
as processed data is essential for thorough follow-up
analysis. Thus, we recommend the open access storage
of genome wide ChIP studies in general. Unfortunately,
the debated data of Wade and colleagues are not easily
accessible. Wade and colleagues might want to consider
storage of their data in a public database to facilitate
data comparison and analysis by others. Below, we dis-
cuss questions related to the dynamic range and repro-
ducibility of ChIP-Chip derived data.
Dynamic range
We accept the claim by Wade and colleagues that the
dynamic range of their study is higher than in our data
set. However, the dynamic range is not a suitable quality
measurement for inter-platform comparison. The main
reason why the dynamic range in our study is lower is
because we used an improved microarray with a higher
probe number and density. With such a higher probe
density the ChIP-DNA is distributed across a greater
number of probes (Figure 1). This would certainly de-
crease the dynamic range but at the same time greatly
increase data quality. This is because binding site detec-
tion can be assisted by comparisons between multiple
neighboring probe signals (Figure 1). Qi and colleagues
tested the relationship between probe density and confi-
dence in binding site detection systematically and came
to the conclusion that “a single high density microarray
(100-bp probe spacing) provides better spatial resolution
than three experimental replicates using lower density
arrays (300-bp probe spacing)” [9].
If the lower dynamic range of our ChIP-Chip data is
the reason why we did not detect the “disputed σ32 sites”
(DSTs), then this would only apply to the targets with
the lowest values. However, the three DSTs with the
highest ChIP-score in the Wade et al. paper (ytfI, ygcI
and yghJ) were not detected in our study. At the same
Figure 1 DNA binding to low and high probe-density microarrays. On low density microarrays, enriched DNA fragments bind to a single
probe (A). This leads to a single strong signal. On high density microarrays the same DNA can bind to more than one specific probe (B). This
decreases the signal intensity but increases the number of signals to be used for binding site detection. The dynamic range of raw data will thus
be decreased compared to low density microarrays but not the data quality.
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in the Wade et al. study (for example grpE, yccV, hepA).
Furthermore, the question remains if our changes to
the ChIP-Chip methodology decrease the dynamic range
as suggested by Wade and colleagues and whether such
a decrease is relevant to this discussion over the
identification of false positives. We believe that our
modifications of the ChIP-Chip protocol do not prohibit
necessary dynamic ranges. Support for this comes from
a SeqA ChIP-Chip experiment with synchronized E. coli
cells [10]. Data was obtained from cells shortly after syn-
chronous initiation of replication (5 or 6 min) using both
the standard protocol [11] and our modified version
[10]. As Wade and colleagues point out the data from
both protocols show similar results (Figure 2). However
the dynamic range appears to be higher with our modi-
fied protocol (98.6) compared to the study with the
standard protocol (5.1; Figure 2). The critical point here
is that the same antibody, the same E. coli strain and the
same microarrays were used for the experiments. Also for
genome wide analyses of SeqA binding in unsynchronized
E. coli cells our changed method gave higher dynamic
ranges compared to the standard protocol [1,11].
Reproducibility
For reliable data, experiments need to be reproducible
and the data from the replicates should be comparable.
For ChIP-Chip data, a straight-forward analysis of repro-
ducibility is difficult. This is because most of the data on
the microarray can be considered background. Even with
a protein of interest binding some hundred times, thiswill be only a small fraction compared to the whole gen-
ome. Subsequently only some probes are expected to
give a relevant signal. The remaining probes will detect
only background DNA. For calculations of correlation
coefficients, as done by Wade and colleagues, this means
that one mainly calculates the correlation of the back-
ground signal. Thus we consider the information gain of
this number limited.
The way we incorporated the reproducibility in our
study was to consider only signals as relevant that
reached a certain threshold in both replicates, as was the
case in the analysis by Wade and colleagues. Since we
have in this way detected in our data almost all known
and published σ32 targets, we consider the reproducibil-
ity of our data as solid.
There are other ways to assess the reproducibility of
ChIP-Chip and ChIP-Seq data. The critical point is to
focus on the target sites. This can be difficult if one lacks
an estimate of the expected number of targets. One way
to deal with this is a stepwise comparison of ranked
target-lists and compute the fraction of overlapping tar-
gets in the highest 10, 20, 30, … %. In our previous study
we used the highest 1.000 probes (out of 40.000) to plot
Venn diagrams for experiment comparison [1]. Such a
quantitation of target reproducibility helps the reader in
data interpretation and should be provided if possible.
Control experiments
While discussion about data quality is certainly import-
ant, it distracts from the main point of our study. The
erroneous data we got for SeqA using the standard
Figure 2 Comparison of SeqA ChIP-Chip data of Sánchez-Romero et al. [11] (red) and Waldminghaus et al. [10] (green). Both studies
used E. coli dnaC2 mutant cells synchronized regarding DNA replication 5 or 6 minutes after initiation and the same antibody for the ChIP
reaction. While Sánchez-Romero and colleagues used the original ChIP-Chip protocol, Waldminghaus and colleagues used the modified protocol.
While both signal patterns correspond to the GATC density (blue) as expected for SeqA, the dynamic range varies between 5.1 for the Sánchez-
Romero et al. experiment and 98.6 for the Waldminghaus et al. experiment. Grey dots show corresponding peaks to a GATC density of≥ 5
(Moving window of 500 bp; step size 100 bp).
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bility was high. In fact we got the highest dynamic range
with our control using a ΔseqA strain and the SeqA anti-
body. However, all of the detected peaks in this experi-
ment must be false. This is actually what we consider
the most dangerous fact about the false positive peaks
we identified. They appear as wonderful, reproducible
hits and not as noise (Figure 3). In our view this is why
such false positive enrichments could easily be accepted
and published as true binding sites. We have discussed
the importance of control experiments as a critical step
to identify false positives [1]. Our control experiment for
the ChIP-Chip detection of the heat shock sigma factor
σ32 in heat shocked E. coli cells was a similar experiment
using non-heat shocked cells. It is remarkable that Wade
and colleagues did not include any ChIP-Chip control
experiment in their σ32 study.
In a recent study, binding of LeuO to the Salmonella
enterica genome was analyzed by ChIP-Chip [12]. Dillon
and colleagues found 261 binding sites using the
ChIPOTle peak finding program. However, they were
aware of the possibility of false positives in ChIP-Chip
data and performed a mock control experiment. In this
control 83 peaks were detected overlapping with the
261 potential LeuO peaks. Dillon and colleagues identi-
fied them as false-positives and considered only theremaining 178 as likely LeuO binding sites. The ap-
proach of Dillon and colleagues supports our argument
that, firstly, false positives are a serious problem in
ChIP-Chip studies and secondly, control ChIP-Chip ex-
periments can help to detect and reduce false-positives.
This is also true for ChIP-Seq where it was shown that
peak-scoring algorithms using 2-sample scoring (scoring
sample vs. control experiment) perform better than
single-sample scoring ones [13].
Are the new sigma32 targets found by Wade and
colleagues real targets or false positives?
Although Wade and colleagues did not include a ChIP-
Chip control experiment in their original study, they
performed ChIP-qPCR experiments of 3 selected loci
out of the 49 “disputed σ32 sites” [7]. Notably, here they
included a non-heat shock control. In their new study
they analyze 3 more loci [8]. The six analyzed loci in-
deed show temperature dependent association with σ32.
These results are contradictory to our ChIP-Chip data
where no significant temperature dependent association
at the respective loci was found. Further experiments
might help to resolve this contradiction. It is even more
important to analyze the 43 remaining DSTs for which
no temperature dependent change in σ32 binding has
been shown so far. We suggest that alternative methods
Figure 3 False positive enrichment peaks resemble true binding sites in ChIP-Chip experiments. Our modified ChIP-Chip protocol (green)
resulted in enrichment data corresponding to the density of GATC binding sites (blue; moving window of 500 bp; step size 100 bp) as expected
for SeqA binding with low signals in low GATC regions (A) and high signals in GATC dense chromosomal regions (B) [1]. The standard ChIP-Chip
protocol (red) resulted in erroneous enrichment peaks in regions with low GATC density (A) and low signals in GATC rich regions (B). The shape
and signal level of the false positive signal example in the ytfI gene region (red in A) and the true positive in the caiC gene region (green in B)
are similar.
Schindler and Waldminghaus BMC Genomics 2013, 14:638 Page 5 of 7
http://www.biomedcentral.com/1471-2164/14/638are needed for verification. Temperature dependent in-
duction of mRNAs at the respective regions could be
considered additional evidence but was not found for
most “disputed σ32 sites” [7,14,15]. Also sequences re-
sembling the well characterized σ32 target promoter se-
quence in the debated regions would promote them as
genuine binding sites. However, Wade et al. note that
for many of the DSTs no such typical binding sequences
could be found [7]. They suggest that at these sites σ32
binding is mediated by transcriptional activators that are
functional only after heat shock. Identification of these
predicted factors would certainly be important for the
discussion about DSTs One possibility to find these fac-
tors would be mChIP, where proteins co-purified in a
ChIP reaction are analyzed [16].
What would be an appropriate alternative method to
clarify disputed ChIP sites? For protein interactions, a
popular approach is to compliment one pull down ex-
periment with the reverse pull down, meaning both pro-
tein partners should be interchangeable as ‘bait’ and
‘prey’. For ChIP experiments the reverse approach would
be to use the DNA as bait to catch the proteins which
are proposed to bind this motif. Such methods have ac-
tually been developed [17,18].Can the ChIP protocol still be improved?
One thing that becomes clear from both our study and
that of the current Wade study is that the experimental
details can change the output of ChIP-Chip experiments
dramatically [1,8]. We did introduce some changes to
the method that completely changed the detected SeqA
binding pattern towards what we believe to be a more
reasonable result. However, we also believe that there is
still room for improvements. One main point in consid-
eration is the use of Spin-X columns for washing of the
IP bound to Protein A agarose beads. We had found that
a problem is the unspecific binding of highly transcribed
and consequently highly crosslinked pieces of DNA to
the column matrix. We suggest that omission of such
columns solves the problem that these unspecific bound
fragments are washed off the column in the elution step
and appear as peaks on the microarray. Instead of using
the columns for collection of the agarose beads we use
simple centrifugation and supernatant removal. Wade
and colleagues make the point that the columns are ne-
cessary to achieve thorough washing. Interestingly they
actually omit the columns in the first step of the proced-
ure where the beads are separated from the cell extract
[8]. While in the original method description this is done
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lect the beads by centrifugation without columns in this
first step just as we suggested to do [8]. This first step is
probably the point where most unspecific binding to the
column occurs and the omission of columns in this step
would be expected to greatly facilitate a reduction in
false signals. The following washing steps might be less
critical in this respect and the use of Spin-X columns
possible or even beneficial. This is certainly a point for
further investigations. A related potential improvement
is the choice of the actual column to be used. The Spin-
X column, for example, is available with various matrix
material and pore sizes. We suspect that if unspecific
binding to the column is a problem, then this should
vary with the pore size and DNA fragment size.
It is noteworthy that other aspects of ChIP-based
methods need to be considered beyond the aspects cov-
ered by the current discussion. Most prominent is the
computational part of the process which provides new
challenges with the advent of ChIP-Seq [9,13]. This com-
putational aspect is certainly important for identifying
false positives.Conclusions
ChIP-Chip or ChIP-Seq are wonderful methods to get
insights into protein binding to genomes. We try to pro-
mote these methods by optimizing them and alerting
other scientists to potential difficulties in data generation
and interpretation. We agree with Wade and colleagues
that surprising non-canonical protein-DNA interactions
can “indicate novel functions for well-studied proteins”.
Examples show that non-canonical binding sites can in-
deed be functional relevant [19,20]. However, we and
many others have detected false positives in ChIP-Chip
experiments and it is not unlikely that some false posi-
tives have not been recognized as such but interpreted
and published as real targets. Wade and colleagues write
in their conclusion that our view that surprising ChIP-
Chip results are often artifacts is a “dogmatic approach”
[8]. Our conclusions in that regard were not meant to be
taken as dogmatic, but rather a respectful caution
against wasteful scientific pursuit that could be based
upon erroneous conclusions. The revision of methods
and criticism of published results of peers is not al-
ways appreciated, and neither is the prospect of hav-
ing one’s own conclusions questioned. However, it is
an essential part of scientific progress. We hope that
other scientists examine the results and argumenta-
tions published by the Wade group and ourselves and
come to their own conclusions. For the future, we
are anticipating new results which we hope will help
clarify the debated issues surrounding the ChIP-Chip
method.Abbreviations
DST: Disputed σ32 targets; ChIP: Chromatin immunoprecipitation;
ChIP-Chip: Chromatin immunoprecipitation with microarray technology;
ChIP-Seq: Chromatin immunoprecipitation with next generation sequencing
technology; RNAP: RNA polymerase.
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Debate and criticism must be welcomed in any scientific endeavour;
however, such debate and criticism must also be based on solid
experimental evidence. While Schindler and Waldminghaus have responded
to our critique [14] of their earlier paper, we note that their response offers
no new experimental evidence or data analysis. Hence, our opinion is
unchanged: the disputed sites of σ32 binding (DSTs) are genuine, and non-
canonical sites identified by ChIP-chip or ChIP-seq are not artifacts to be
disregarded. We feel that three points require specific attention:
1. The modifications to the ChIP method proposed by Waldminghaus
and colleagues do not improve data quality. By directly comparing the
two methods in targeted, controlled ChIP assays, we have clearly
demonstrated that the standard ChIP method is more effective than the
modified method at detecting association of σ32 with both well-established
targets and DSTs. Additional experiments with the transcription factor AraC
confirm that the general outcome of ChIP experiments is unchanged by the
use of Spin-X columns during the wash steps; if anything, use of Spin-X
columns increases signal. We note that most ChIP studies do not use Spin-X
columns until the wash steps, and this modification to the method was
applied before the study of Waldminghaus and Skarstad [1], e.g. [21]. Instead
of representing a methodological improvement, we propose that
Waldminghaus and Skarstad’s σ32 ChIP-chip experiments simply had reduced
sensitivity due to a combination of the ChIP protocol, antibody, and/or
growth conditions, all of which differed from our own.
Although we have focused on σ32, an independent study of SeqA, using the
standard ChIP-chip method, yielded almost identical data to those generated
by Waldminghaus and colleagues. This similarity was recently noted by a
group who successfully used the standard ChIP method to measure DNA
binding by SeqA [22]. The data presented by Schindler and Waldminghaus
in Figure 2A is misleading because the scales are not comparable for the
two datasets, and the time-points after replication initiation are different
(signal at the replication origin is expected to drop rapidly following
replication initiation).
2. Most, if not all DSTs are genuine sites of σ32 association. Many lines of
evidence support this. First, we tested 6 DSTs using ChIP/qPCR, with an
appropriate control; all 6 targets were confirmed. Whilst the remaining 43
DSTs were not tested, our data strongly suggest that most are genuine sites
of σ32 association. We find it unrealistic to suggest that every single target
identified by a ChIP-chip or ChIP-seq experiment should be validated
individually. Second, while the standard ChIP protocol reliably yields higher
enrichment values at DSTs in targeted experiments, the modified method
also detects σ32 binding at 2 out of 4 DSTs tested. Moreover, the ranking of
DSTs as a group increases significantly among all genomic regions following
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U Test, p = 1e-6), as would be expected for genuine sites of σ32 association.
Both of these findings support the idea that discrepancies between the
datasets are related to differences in assay sensitivity, not the validity of
targets. Third, nine of the DSTs were identified in independent
transcriptomic studies [14,15] and we have shown that RNA polymerase
levels increase at two of four DSTs tested following overexpression of σ32.
These two DSTs were not identified by either transcriptomic study,
indicating that such experiments are not necessarily sensitive enough to
detect all regulated RNAs. Fourth, DSTs are more likely to be located in
intergenic regions than expected by chance (Binomial Test, p = 0.00033).
Schindler and Waldminghaus suggest that DSTs are not real σ32 binding
sites because many of them lack detectable motifs and/or were not
detected in transcriptomic studies. However, since DSTs are generally weakly
bound, they would be expected to bind more degenerate motifs and be
associated with more subtle changes in transcription.
3. Non-canonical sites for DNA-binding proteins are often real, and
studying them is not a wasteful scientific pursuit. We reassert that the
headline conclusion of Waldminghuas and Skarstad’s paper “ChIP on Chip:
surprising results are often artifacts”, and their subsequent criticism of work
from multiple laboratories, is highly misleading. We and others have
identified many non-canonical targets for bacterial DNA-binding proteins
that have been validated in controlled experiments. In fact, 15 of the 47 σ32
targets identified by Waldminghaus and Skarstad are non-canonical (located
inside genes or not associated with detectable regulation in transcriptomic
studies) and, by their own logic, should be mistrusted. Although ChIP-chip
and ChIP-seq studies in bacteria have been limited in number, a recent
large-scale ChIP-seq study in Mycobacterium tuberculosis identified hundreds
of non-canonical transcription factor binding sites [23]. We conclude that
non-canonical binding sites for bacterial DNA-binding proteins occur often
and should be the subject of further study precisely because they do not
conform to the text-book model of transcription regulation.
ChIP-chip data from our original study [7] are now publicly available from
the EMBL-EBI ArrayExpress database (E-MTAB-1849).
Received: 18 June 2013 Accepted: 18 September 2013
Published: 22 September 2013
References
1. Waldminghaus T, Skarstad K: ChIP on Chip: surprising results are often
artifacts. BMC Genomics 2010, 11:414.
2. Waldminghaus T, Skarstad K: The Escherichia coli SeqA protein. Plasmid
2009, 61(3):141–150.
3. Grainger DC, Overton TW, Reppas N, Wade JT, Tamai E, Hobman JL,
Constantinidou C, Struhl K, Church G, Busby SJ: Genomic studies with
Escherichia coli MelR protein: applications of chromatin
immunoprecipitation and microarrays. J Bacteriol 2004, 186(20):6938–6943.
4. Reppas NB, Wade JT, Church GM, Struhl K: The transition between
transcriptional initiation and elongation in E. coli is highly variable and
often rate limiting. Mol Cell 2006, 24(5):747–757.
5. Kidder BL, Hu G, Zhao K: ChIP-Seq: technical considerations for obtaining
high-quality data. Nat Immunol 2011, 12(10):918–922.
6. Aparicio O, Geisberg JV, Struhl K: Chromatin immunoprecipitation for
determining the association of proteins with specific genomic
sequences in vivo. Curr Protoc Cell Biol 2004, Chapter 17:Unit 17.7.
7. Wade JT, Castro Roa D, Grainger DC, Hurd D, Busby SJ, Struhl K, Nudler E:
Extensive functional overlap between sigma factors in Escherichia coli.
Nat Struct Mol Biol 2006, 13(9):806–814.
8. Bonocora RP, Fitzgerald DM, Stringer AM, Wade JT: Non-canonical protein-
DNA interactions identified by ChIP are not artifacts. BMC Genomics 2013,
14(1):254.
9. Qi Y, Rolfe A, MacIsaac KD, Gerber GK, Pokholok D, Zeitlinger J, Danford T,
Dowell RD, Fraenkel E, Jaakkola TS, et al: High-resolution computational
models of genome binding events. Nat Biotechnol 2006, 24(8):963–970.
10. Waldminghaus T, Weigel C, Skarstad K: Replication fork movement and
methylation govern SeqA binding to the Escherichia coli chromosome.
Nucleic Acids Res 2012, 40(12):5465–5476.
11. Sanchez-Romero MA, Busby SJ, Dyer NP, Ott S, Millard AD, Grainger DC:
Dynamic distribution of SeqA protein across the chromosome of
Escherichia coli K-12. mBio 2010, 1(1):e0012–00010.12. Dillon SC, Espinosa E, Hokamp K, Ussery DW, Casadesus J, Dorman CJ: LeuO
is a global regulator of gene expression in Salmonella enterica serovar
Typhimurium. Mol Microbiol 2012, 85(6):1072–1089.
13. Wilbanks EG, Facciotti MT: Evaluation of algorithm performance in ChIP-
seq peak detection. PLoS One 2010, 5(7):e11471.
14. Zhao K, Liu M, Burgess RR: The global transcriptional response of
Escherichia coli to induced sigma 32 protein involves sigma 32 regulon
activation followed by inactivation and degradation of sigma 32 in vivo.
J Biol Chem 2005, 280(18):17758–17768.
15. Nonaka G, Blankschien M, Herman C, Gross CA, Rhodius VA: Regulon and
promoter analysis of the E. coli heat-shock factor, sigma32, reveals a
multifaceted cellular response to heat stress. Genes Dev 2006, 20
(13):1776–1789.
16. Lambert JP, Mitchell L, Rudner A, Baetz K, Figeys D: A novel proteomics
approach for the discovery of chromatin-associated protein networks.
Mol Cell Proteomics 2009, 8(4):870–882.
17. Butala M, Busby SJ, Lee DJ: DNA sampling: a method for probing protein
binding at specific loci on bacterial chromosomes. Nucleic Acids Res 2009,
37(5):e37.
18. Dejardin J, Kingston RE: Purification of proteins associated with specific
genomic Loci. Cell 2009, 136(1):175–186.
19. Lefrancois P, Auerbach RK, Yellman CM, Roeder GS, Snyder M: Centromere-
like regions in the budding yeast genome. PLoS Genet 2013, 9(1):
e1003209.
20. Wong D, Teixeira A, Oikonomopoulos S, Humburg P, Lone IN, Saliba D,
Siggers T, Bulyk M, Angelov D, Dimitrov S, et al: Extensive characterization
of NF-kappaB binding uncovers non-canonical motifs and advances the
interpretation of genetic functional traits. Genome Biol 2011, 12(7):R70.
21. Rhodius VA, Wade JT: Technical Considerations in using DNA Microarrays
to Define Regulons. Methods 2009, 47:63–72.
22. Joshi MC, Magnan D, Montminy TP, Lies M, Stepankiw N, Bates D:
Regulation of Sister Chromosome Cohesion by the Replication Fork
Tracking Protein SeqA. PLoS Genet 2013, 9:e1003673.
23. Galagan JE, Minch K, Peterson M, Lyubetskaya A, Azizi E, Sweet L, Gomes A,
Rustad T, Dolganov G, Glotova I, Abeel T, Mahwinney C, Kennedy AD, Allard
R, Brabant W, Krueger A, Jaini S, Honda B, Yu WH, Hickey MJ, Zucker J, Garay
C, Weiner B, Sisk P, Stolte C, Winkler JK, Van de Peer Y, Iazzetti P, Camacho
D, Dreyfuss J, Liu Y, Dorhoi A, Mollenkopf HJ, Drogaris P, Lamontagne J,
Zhou Y, Piquenot J, Park ST, Raman S, Kaufmann SH, Mohney RP, Chelsky D,
Moody DB, Sherman DR, Schoolnik GK: The Mycobacterium tuberculosis
regulatory network and hypoxia. Nature 2013, 499:178–83.
doi:10.1186/1471-2164-14-638
Cite this article as: Schindler and Waldminghaus: “Non-canonical
protein-DNA interactions identified by ChIP are not artifacts”: response.
BMC Genomics 2013 14:638.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
